Liao KM

References (2)

Title : Dipeptidyl Peptidase-4 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients with COPD and Diabetes: A Nationwide Retrospective Cohort Study - Ho_2026_Int.J.Chron.Obstruct.Pulmon.Dis_21_608033
Author(s) : Ho CH , Shao YC , Wu YC , Liao KM
Ref : Int J Chron Obstruct Pulmon Dis , 21 :608033 , 2026
Abstract :
PubMedSearch : Ho_2026_Int.J.Chron.Obstruct.Pulmon.Dis_21_608033
PubMedID: 42232870

Title : Dipeptidyl peptidase IV inhibitors and the risk of mycobacterial pulmonary infections in type 2 diabetes mellitus - Wang_2023_J.Infect.Public.Health_16_1709
Author(s) : Wang CY , Liao KM , Wang YH , Chen KH , Chuang S , Liu CJ , Shu CC , Wang HC
Ref : J Infect Public Health , 16 :1709 , 2023
Abstract :
PubMedSearch : Wang_2023_J.Infect.Public.Health_16_1709
PubMedID: 37729686